Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development.
Tackling type 2 diabetes-associated cardiovascular and renal comorbidities: a key challenge for drug development.
Expert Opin Investig Drugs. 2020 Dec 17;:
Authors: Adeghate EA, Kalász H, Al Jaberi S, Adeghate J, Tekes K
PMID: 33327794 [PubMed - as supplied by publisher]
Source: Expert Opinion on Investigational Drugs - Category: Drugs & Pharmacology Tags: Expert Opin Investig Drugs Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Heart